Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The U.S. government's principal agency for cancer research
An NCI study finds long-term increased risk of cancer death following a common treatment for hyperthyroidism.
Researchers are interested in combining PARP inhibitors with immunotherapies for pancreatic and other cancers with defects in DNA repair.
Researchers are continuing to identify potential biomarkers or specific clinical factors to identify the best candidates for treatments.
These proteins normally act to stop abnormal cell growth, but they can lose this function in cancer cells.
The Childhood Cancer Data Initiative aims to change the course of how cancer in young people is prevented, diagnosed and treated.
Special section on adults ages 20 to 49 shows higher cancer incidence and mortality for women than men.
While the team has found some interesting connections, there’s still a mountain of data to explore, say the study’s authors.
Rates of the subtypes increased among all ethnic groups, and increased the most among black women, who also had the lowest survival rates.
More patients with metastatic cancer and bone metastases are living longer today, so the need to address bone pain has increased.
A conversation with NCI’s Howard Parnes, MD
Complications of cancer immunotherapy
The trial is part of an effort by the Children’s Oncology Group and others to evaluate treatment regimens for children with cancer.
The approach is called an in situ vaccine because it uses something in the body (in situ)—here, a tumor—to help create an immune response.
Even small changes in physical fitness can make it possible for people to maintain their quality of life as cancer progresses.
Given the long timeline needed for human studies, people today should not expect this technology to be proven and fully approved for years.
“The simplicity of this approach means that it is promising to take forward” to a human vaccine, researchers say.
The genomic research field has been trending towards more data points, so the emergence of low-coverage sequencing.
The study suggests that increasing T cells’ exposure to potassium may make cancer immunotherapies more effective.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.